Search

Author/Creator Garcia, Agustin

1. 2022-RA-722-ESGO Phase 2 study assessing the efficacy of adding AL3818 (Catequentinib Dihydrochloride, Anlotinib Hydrochloride) to chemotherapies in subjects with platinum resistant ovarian carcinoma. (20th October 2022)

Authors:
Miller, David Scott; Carlson, Matthew; Lea, Jayanthi; Li, Zhe; Gan, May; Chen, Judy; Garcia, Agustin; Schlumbrecht, Matthew; Pearson, Matt; Huang, Marilyn
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A259
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗